| Literature DB >> 26633298 |
Abstract
Up to 12% of European men aged 55-69 years diagnosed with prostate cancer have high-risk disease and thus are at increased risk of mortality. There remains a lack of consensus on definitive treatment for prostate cancer, although both radiation therapy and radical prostatectomy are frequently utilized. Furthermore, the different types of radiation and surgical options also increase the complexity of deciding on a single treatment, as does the use of multimodal treatment plans. Here, we provide an overview of radiation therapy and radical prostatectomy in treating high-risk prostate cancer.Entities:
Mesh:
Year: 2015 PMID: 26633298 DOI: 10.1159/000441736
Source DB: PubMed Journal: Oncol Res Treat ISSN: 2296-5270 Impact factor: 2.825